NCT03466073 - A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 28, 2018

Primary Completion Date

April 2, 2019

Study Completion Date

April 2, 2019

Conditions

Community-acquired Pneumonia

Interventions

DRUG

Recombinant Human Plasma Gelsolin

Recombinant human plasma gelsolin lyophilized for reconstitution, reconstituted in sterile water

OTHER

Normal Saline Placebo

Normal saline in volume equivalent to drug

Trial Locations (8)

Footscray Hospital, Footscray

Box Hill Hospital, Box Hill

LTD Geo Hospitals, Mtskheta Multiprofile Medical Center, Mtskheta

JSC Rustavi Central Hospital, Rustavi

Cairns Hospital, Cairns

LTD Central University Clinic After Academic N. Kipshidze, Tbilisi

LTD S. Khechinashvili University Hospital, Tbilisi

LTD 5th Clinical Hospital, Tbilisi